The Food and Drug Administration is mulling over conducting its own evaluation of the levels of DNA in COVID-19 vaccines, an FDA official has disclosed.
“I’ll say that that is something that’s being discussed,” Dr. Tracy Hoeg, a senior adviser to the FDA’s commissioner, told members of the Centers for Disease Control and Prevention’s vaccine advisory panel on Sept. 19.
Before the panel’s members unanimously recommended during the meeting that the CDC roll back COVID-19 vaccine recommendations, a number expressed concerns about growing evidence of higher-than-allowed levels of DNA in the vaccines, the spreadofthevaccinebeyond the injection site, and the long-term persistence of messenger ribonucleic acid (mRNA)—a key part of the Pfizer-BioNTech and Moderna shots.
The CDC has described mRNA as the entity teaching cells how to make copies of the spike protein to enable protection when the real virus, with its own spike protein, attacks the body. “After the mRNA delivers the instructions, your cells break it down and get rid of it,” a CDC graphic states.
Retsef Levi, chair of the advisory panel’s COVID-19 immunization workgroup, showed the graphic during the meeting.
“We have a range of things on the mRNA platforms that really suggests that it doesn’t work as intended,” Levi said, citing issues such as the spread of spike protein and mRNA into various parts of the body and “DNA contamination.”
Hellbound and Down 